Marks, Dustin H.
Okhovat, Jean-Phillip
Hagigeorges, Dina
Manatis-Lornell, Athena J.
Isakoff, Steven J.
Lacouture, Mario E.
Senna, Maryanne M. http://orcid.org/0000-0002-7813-520X
Article History
Received: 5 February 2019
Accepted: 15 February 2019
First Online: 26 February 2019
Compliance with ethical standards
:
: Dr. Lacouture has a consultant/speaking role with Legacy Healthcare Services, Adgero Bio Pharmaceuticals, Amryt Pharmaceuticals, Celldex Therapeutics, Debiopharm, Galderma Research and Development, Johnson and Johnson, Novocure Inc, Lindi, Merck Sharp and Dohme Corporation, Helsinn Healthcare SA, Janssen Research & Development LLC, Menlo Therapeutics, Novartis Pharmaceuticals Corporation, F. Hoffmann-La Roche AG, AbbVie Inc, Boehringer Ingelheim Pharma Gmbh & Co. KG, Allergan Inc, Amgen Inc, E.R. Squibb & Sons LLC, EMD Serono Inc, Astrazeneca Pharmaceuticals LP, Genentech Inc, Leo Pharma Inc, Seattle Genetics, Bayer, Manner SAS, Lutris, Pierre Fabre, Paxman Coolers, Adjucare, Dignitana, Biotechspert, Teva Mexico, Parexel, OnQuality Pharmaceuticals Ltd, Novartis, Harborside, Wiley, and Takeda Millenium. Dr. Lacouture also receives research funding from Berg, Bristol-Myers Squibb, Lutris, Paxman, Novocure, US Biotest, and Veloce, and is funded in part through the NIH/NCI Cancer Center Support Grant P30 CA008748. Mr. Marks declares that he has no conflict of interest. Dr. Okhovat declares that he has no conflict of interest. Ms. Hagigeorges declares that she has no conflict of interest. Ms. Manatis-Lornell declares that she has no conflict of interest. Dr. Isakoff declares that he has no conflict of interest. Dr. Senna declares that she has no conflict of interest.
: As this study was a systematic review and did not involve contact with patients or patient information, it was not applicable for Informed consent to be obtained.
: This article does not contain any studies with human participants or animals performed by any of the authors.